Neutrophilia independently predicts death in tuberculosis

European Respiratory Journal

Volumn 42, Issue 6, 2013, Pages 1752-1757

  Lowe, David M ^a,b   Bandara, Asela K ^c   Packe, Geoffrey E ^d   Barker, Richard D ^e   Wilkinson, Robert J ^a,b,f   Griffiths, Christopher J ^c   Martineau, Adrian R ^a,c,f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Newham Chest Clinic   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BACTERIUM DETECTION; BLOOD CULTURE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL COUNT; NEUTROPHILIA; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

ADULT; AGED; BLOOD CELL COUNT; FEMALE; GREAT BRITAIN; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; NEUTROPHILS; PREVALENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84890062410     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00140913     Document Type: Letter

References (10)

1. Lowe DM, Redford PS, Wilkinson RJ, et al. Neutrophils in tuberculosis: friend or foe? Trends Immunol 2012; 33: 14-25.
2. Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007; 117: 1988-1994.
3. Sugawara I, Udagawa T, Yamada H. Rat neutrophils prevent the development of tuberculosis. Infect Immun 2004; 72: 1804-1806.
4. Nandi B, Behar SM. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med 2011; 208: 2251-2262.
5. Brahmbhatt S, Black GF, Carroll NM, et al. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin Exp Immunol 2006; 146: 243-252.
6. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
7. Lawn SD, Kerkhoff AD, Vogt M, et al. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 2012; 54: 1071-1079.
8. Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J 2008; 31: 1256-1260.
9. Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005; 7: 187-196.
10. Ferrand RA, Herman J, Elgalib A, et al. Septic shock and multi-organ failure in HIV infection - 'sepsis tuberculosa gravissima'. Int J STD AIDS 2006; 17: 562-564.